Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

In overweight patients with chronic hepatitis C, circulating insulin is associated with hepatic fibrosis: implications for therapy.

Journal of hepatology - 1 Dec 2003

Hickman Ingrid J, Powell Elizabeth E, Prins Johannes B, Clouston Andrew D, Ash Susan, Purdie David M, Jonsson Julie R

Abstract excerpt

BACKGROUND/AIMS: Host factors such as increased body mass index (BMI) and genotype-specific viral factors contribute to the development of steatosis in patients with chronic hepatitis C (HCV). We hypothesized that host metabolic factors associated with increased BMI may play a role in disease progression. METHODS: Fasting serum was collected from 160 patients with chronic HCV at the time of liver biopsy and 45...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Body Mass Index
Share to Fatty Liver

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepacivirus

Share to Hepatitis C, Chronic

Share to Insulin

Share to Leptin

Share to Liver Cirrhosis

Share to Obesity

Source

Identifiers

PMID: 14642624
DOI: 10.1016/s0168-8278(03)00463-x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

In overweight patients with chronic hepatitis C, circulating insulin is associated with hepatic fibrosis: implications for therapy.PMID 14642624Read ↗

Insulin resistance is a cause of steatosis and fibrosis progression in chronic hepatitis C.Semantic proximity Read ↗

Glucose intolerance and hypoadiponectinemia are already present in lean patients with chronic hepatitis C infected with genotype non-3 viruses.Semantic proximity Read ↗

Insulin resistance is associated with chronic hepatitis C virus infection and fibrosis progression [corrected].Semantic proximity Read ↗

Factors Associated with Insulin Resistance in Patients with Chronic HCV Genotype 1 Infection without Obesity or Type 2 Diabetes.Semantic proximity Read ↗

Serum leptin levels correlate with hepatic steatosis in chronic hepatitis C.Semantic proximity Read ↗

Insulin resistance and liver injury in hepatitis C is not associated with virus-specific changes in adipocytokines.Semantic proximity Read ↗

Association of serum adipocytokines with hepatic steatosis and fibrosis in patients with chronic hepatitis C.Semantic proximity Read ↗

Genotype-specific interactions of insulin resistance, steatosis, and fibrosis in chronic hepatitis C.Semantic proximity Read ↗

Prevalence of insulin resistance in chronic hepatitis C genotype 1 and 3 patients.Semantic proximity Read ↗

Serum leptin and ghrelin in chronic hepatitis C patients with steatosis.Semantic proximity Read ↗

Insulin resistance and liver steatosis in chronic hepatitis C infection genotype 3.Semantic proximity Read ↗

Insulin resistance and response to therapy in patients infected with chronic hepatitis C virus genotypes 2 and 3.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.